The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 6.79 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.63 — no flag raisedOK
- Earnings quality 50/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as ORASURE TECHNOLOGIES INC reports it. History and quarterly detail are in the app.
- Products and services$109.1M
- HIV$49.8M
- Sample Management Solutions$38.4M
- COVID-19$13.8M
- Non-product and services revenues$6.0M
Leadership changes
From ORASURE TECHNOLOGIES INC's own filings, the day they're filed.
- John D. Bertrand · director · appointmenteff. 2026-04-16
- Steven Boyd · director · appointmenteff. 2025-10-28
- John P. Kenny · chair · appointmenteff. 2025-10-28
Latest filings
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-06-11
- 8-K · Company announcement2026-06-03
- 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ORASURE TECHNOLOGIES INC, every answer cited to the official filings🔒
- The Intelligence Brief — added when ORASURE TECHNOLOGIES INC's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.